Published in Mol Endocrinol on July 01, 1998
An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. Cancer Cell (2010) 6.76
Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate cancer. Eur Urol (2009) 3.11
Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: results from a pilot clinical study. Sci Transl Med (2015) 2.55
Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system. Br J Cancer (1999) 2.34
A randomized phase 1 study of testosterone replacement for patients with low-risk castration-resistant prostate cancer. Eur Urol (2009) 2.26
The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines. Cancer Res (2009) 1.88
Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium. Proc Natl Acad Sci U S A (2001) 1.43
Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells. Proc Natl Acad Sci U S A (2000) 1.36
Androgen receptor remains critical for cell-cycle progression in androgen-independent CWR22 prostate cancer cells. Am J Pathol (2006) 1.33
Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer. Nat Med (2016) 1.22
Pomegranate polyphenols down-regulate expression of androgen-synthesizing genes in human prostate cancer cells overexpressing the androgen receptor. J Nutr Biochem (2008) 1.17
DNA licensing as a novel androgen receptor mediated therapeutic target for prostate cancer. Endocr Relat Cancer (2009) 1.12
Androgen and its receptor promote Bax-mediated apoptosis. Mol Cell Biol (2006) 1.10
Androgen suppresses proliferation of castration-resistant LNCaP 104-R2 prostate cancer cells through androgen receptor, Skp2, and c-Myc. Cancer Sci (2011) 1.10
Cyclin E as a coactivator of the androgen receptor. J Cell Biol (2000) 1.08
Regulation of mitochondrial DNA content and cancer. Mitochondrion (2006) 1.07
Prolonged androgen deprivation leads to downregulation of androgen receptor and prostate-specific membrane antigen in prostate cancer cells. Int J Oncol (2012) 1.06
The F-box protein SKP2 mediates androgen control of p27 stability in LNCaP human prostate cancer cells. BMC Cell Biol (2002) 1.06
Androgen-induced proliferative quiescence in prostate cancer cells: the role of AS3 as its mediator. Proc Natl Acad Sci U S A (2000) 1.05
SUMOylation of pontin chromatin-remodeling complex reveals a signal integration code in prostate cancer cells. Proc Natl Acad Sci U S A (2007) 1.03
Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer. J Biomed Sci (2011) 1.03
Liver X receptor β activation induces pyroptosis of human and murine colon cancer cells. Cell Death Differ (2014) 1.02
Suppression of androgen receptor signaling and prostate specific antigen expression by (-)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cells. Cancer Lett (2008) 0.99
Androgen receptor targets NFkappaB and TSP1 to suppress prostate tumor growth in vivo. Int J Cancer (2007) 0.99
Orphan nuclear receptors as targets for drug development. Pharm Res (2010) 0.97
The liver X receptor agonist T0901317 acts as androgen receptor antagonist in human prostate cancer cells. Biochem Biophys Res Commun (2007) 0.96
Androgens transduce the G alphas-mediated activation of protein kinase A in prostate cells. Cancer Res (2008) 0.95
Chemical genetics approach to restoring p27Kip1 reveals novel compounds with antiproliferative activity in prostate cancer cells. BMC Biol (2010) 0.92
Antisense MDM2 enhances the response of androgen insensitive human prostate cancer cells to androgen deprivation in vitro and in vivo. Prostate (2008) 0.91
The diverse and contrasting effects of using human prostate cancer cell lines to study androgen receptor roles in prostate cancer. Asian J Androl (2008) 0.90
EGFR/HER-targeted therapeutics in ovarian cancer. Future Med Chem (2012) 0.90
Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1. Oncotarget (2015) 0.90
Androgen receptor drives cellular senescence. PLoS One (2012) 0.89
Chemotherapy and its evolving role in the management of advanced prostate cancer. Asian J Androl (2014) 0.88
Caffeic acid phenethyl ester suppresses proliferation and survival of TW2.6 human oral cancer cells via inhibition of Akt signaling. Int J Mol Sci (2013) 0.88
Castration-resistant prostate cancer: targeted therapies and individualized treatment. Oncologist (2011) 0.85
Cholestane-3β, 5α, 6β-triol suppresses proliferation, migration, and invasion of human prostate cancer cells. PLoS One (2013) 0.85
Modulation of androgen receptor signaling in hormonal therapy-resistant prostate cancer cell lines. PLoS One (2011) 0.84
Difference in protein expression profile and chemotherapy drugs response of different progression stages of LNCaP sublines and other human prostate cancer cells. PLoS One (2013) 0.83
Androgen deprivation-induced senescence promotes outgrowth of androgen-refractory prostate cancer cells. PLoS One (2013) 0.83
Can a single model explain both breast cancer and prostate cancer? Theor Biol Med Model (2007) 0.83
Ligand activation of the androgen receptor downregulates E-cadherin-mediated cell adhesion and promotes apoptosis of prostatic cancer cells. Neoplasia (2003) 0.83
Retinoids regulate the formation and degradation of gap junctions in androgen-responsive human prostate cancer cells. PLoS One (2012) 0.83
Quantitative mathematical modeling of PSA dynamics of prostate cancer patients treated with intermittent androgen suppression. J Mol Cell Biol (2012) 0.82
Androgen suppresses the proliferation of androgen receptor-positive castration-resistant prostate cancer cells via inhibition of Cdk2, CyclinA, and Skp2. PLoS One (2014) 0.81
Caffeic Acid phenethyl ester as a potential treatment for advanced prostate cancer targeting akt signaling. Int J Mol Sci (2013) 0.80
Mathematically modelling and controlling prostate cancer under intermittent hormone therapy. Asian J Androl (2012) 0.80
Androgen via p21 inhibits tumor necrosis factor alpha-induced JNK activation and apoptosis. J Biol Chem (2009) 0.80
Chinese red yeast rice inhibition of prostate tumor growth in SCID mice. Cancer Prev Res (Phila) (2011) 0.80
The combination of the prodrugs perforin-CEBPD and perforin-granzyme B efficiently enhances the activation of caspase signaling and kills prostate cancer. Cell Death Dis (2014) 0.79
Androgen receptor coactivators that inhibit prostate cancer growth. Am J Clin Exp Urol (2014) 0.78
Testosterone Therapy Among Prostate Cancer Survivors. Sex Med Rev (2016) 0.77
Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility. BMC Cancer (2015) 0.77
The Role of Testosterone in the Treatment of Castration-Resistant Prostate Cancer. Cancer J (2016) 0.76
Characterization of a novel metastatic prostate cancer cell line of LNCaP origin. Prostate (2015) 0.75
Crosstalk of the Androgen Receptor with Transcriptional Collaborators: Potential Therapeutic Targets for Castration-Resistant Prostate Cancer. Cancers (Basel) (2017) 0.75
Testosterone therapy and prostate cancer. Transl Androl Urol (2016) 0.75
Longitudinal tracking of subpopulation dynamics and molecular changes during LNCaP cell castration and identification of inhibitors that could target the PSA-/lo castration-resistant cells. Oncotarget (2016) 0.75
Androgen-independent LNCaP cells are a subline of LNCaP cells with a more aggressive phenotype and androgen suppresses their growth by inducing cell cycle arrest at the G1 phase. Int J Mol Med (2017) 0.75
4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway. Genes Dev (1998) 6.89
Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev (2001) 6.15
The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev (1997) 5.58
Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev (2001) 5.12
The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp Cell Res (1999) 4.66
Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. Genes Dev (1994) 3.70
Attenuation in the control of SV40 gene expression. Cell (1982) 3.32
Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt. Oncogene (2006) 3.17
Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3. Proc Natl Acad Sci U S A (2001) 3.02
Akt/Protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria. Mol Cell Biol (1999) 2.93
Secretory proteins move through the endoplasmic reticulum membrane via an aqueous, gated pore. Cell (1994) 2.62
Selective retention of dihydrotestosterone by prostatic nuclei. Nature (1968) 2.60
Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J Clin Invest (1995) 2.53
Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene (1994) 2.45
Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. J Clin Invest (1998) 2.43
Neoplastic transformation by the human gene N-myc. Mol Cell Biol (1987) 2.17
Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. Am J Pathol (1997) 1.99
Predictors of family functioning and change 3 years after traumatic brain injury in children. Arch Phys Med Rehabil (1996) 1.83
Myc-mediated apoptosis is blocked by ectopic expression of Bcl-2. Mol Cell Biol (1993) 1.79
Sequence-specific transcriptional activation by Myc and repression by Max. Mol Cell Biol (1993) 1.77
Receptor proteins for androgens. On the role of specific proteins in selective retention of 17-beta-hydroxy-5-alpha-androstan-3-one by rat ventral prostate in vivo and in vitro. J Biol Chem (1969) 1.74
Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Endocrinology (2000) 1.72
Ubiquitous receptor: a receptor that modulates gene activation by retinoic acid and thyroid hormone receptors. Proc Natl Acad Sci U S A (1994) 1.69
Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. J Vasc Surg (1996) 1.66
Human prostate tumor growth in athymic mice: inhibition by androgens and stimulation by finasteride. Proc Natl Acad Sci U S A (1996) 1.61
c-Myc induces the expression and activity of ornithine decarboxylase. Cell Growth Differ (1993) 1.60
Soluble TNF-alpha receptor and IL-1 receptor antagonist elevation in BAL in active pulmonary TB. Eur Respir J (1999) 1.60
Loss of heterozygosity in cervical carcinoma: subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22-q24. Proc Natl Acad Sci U S A (1994) 1.55
Source of elastin-degrading enzymes in mycotic aortic aneurysms: bacteria or host inflammatory response? Cardiovasc Surg (1999) 1.53
Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation. Cancer Res (1994) 1.52
Attenuation of late simian virus 40 mRNA synthesis is enhanced by the agnoprotein and is temporally regulated in isolated nuclear systems. Mol Cell Biol (1985) 1.43
Akt, a target of phosphatidylinositol 3-kinase, inhibits apoptosis in a differentiating neuronal cell line. Mol Cell Biol (1998) 1.41
The role of RNA molecules in transduction of the proto-oncogene c-fps. Cell (1986) 1.39
Transcription enhancer factor 1 interacts with a basic helix-loop-helix zipper protein, Max, for positive regulation of cardiac alpha-myosin heavy-chain gene expression. Mol Cell Biol (1997) 1.37
Selective polyamine-binding proteins. Spermine binding by an androgen-sensitive phosphoprotein. Biochim Biophys Acta (1978) 1.37
Attenuation in SV40 as a mechanism of transcription-termination by RNA polymerase B. Nucleic Acids Res (1984) 1.35
Detection of clonal T-cell receptor gamma gene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE). J Invest Dermatol (1994) 1.34
Outcome of pediatric traumatic brain injury at three years: a cohort study. Arch Phys Med Rehabil (1994) 1.31
Repeated CT elements bound by zinc finger proteins control the absolute and relative activities of the two principal human c-myc promoters. Mol Cell Biol (1993) 1.29
Cellular receptors and mechanisms of action of steroid hormones. Int Rev Cytol (1975) 1.29
Cholestenoic acid is a naturally occurring ligand for liver X receptor alpha. Endocrinology (2000) 1.28
Androgen receptors. Steroid- and tissue-specific retention of a 17 beta-hydroxy-5 alpha-androstan-3-one-protein complex by the cell nuclei of ventral prostate. J Biol Chem (1971) 1.28
Substitution of aspartic acid-686 by histidine or asparagine in the human androgen receptor leads to a functionally inactive protein with altered hormone-binding characteristics. Mol Endocrinol (1991) 1.27
The effect of multidimensional exercises on balance, mobility, and fall risk in community-dwelling older adults. Phys Ther (1997) 1.25
Vascular smooth muscle cell apoptosis in abdominal aortic aneurysms. Coron Artery Dis (1997) 1.25
Mutant presenilin-1 induces apoptosis and downregulates Akt/PKB. J Neurosci (1999) 1.24
Pharmacologic suppression of experimental abdominal aortic aneurysms: acomparison of doxycycline and four chemically modified tetracyclines. J Vasc Surg (1998) 1.21
Attenuation may regulate gene expression in animal viruses and cells. CRC Crit Rev Biochem (1985) 1.21
Site of premature termination of late transcription of simian virus 40 DNA: enhancement by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole. Proc Natl Acad Sci U S A (1982) 1.20
Family functioning and children's academic performance and behavior problems in the year following traumatic brain injury. Arch Phys Med Rehabil (1994) 1.19
Rapid effect of testosterone on ribonucleic acid polymerase activity of rat ventral prostate. Endocrinology (1965) 1.19
Induction of cell cycle progression and acceleration of apoptosis are two separable functions of c-Myc: transrepression correlates with acceleration of apoptosis. Mol Cell Biol (2000) 1.18
Activation of NF-kappa B by bradykinin through a Galpha(q)- and Gbeta gamma-dependent pathway that involves phosphoinositide 3-kinase and Akt. J Biol Chem (2000) 1.17
p21 Disrupts the interaction between cdk2 and the E2F-p130 complex. Mol Cell Biol (1996) 1.16
Receptor-proteims for androgens and the mode of action of androgens on gene transcription in ventral prostate. Vitam Horm (1969) 1.16
Steroid structure and androgenic activity. Specificities involved in the receptor binding and nuclear retention of various androgens. J Biol Chem (1973) 1.14
The use of anti-steroid antibodies in the characterization of steroid receptors. J Biol Chem (1975) 1.14
Recovery trends over three years following pediatric traumatic brain injury. Arch Phys Med Rehabil (1995) 1.14
Immunohistochemical localization of androgen receptor in the human endometrium, decidua, placenta and pathological conditions of the endometrium. Hum Reprod (1992) 1.11
Molecular cloning of new human TR2 receptors: a class of steroid receptor with multiple ligand-binding domains. Biochem Biophys Res Commun (1989) 1.10
Epidermal growth factor receptor activation in androgen-independent but not androgen-stimulated growth of human prostatic carcinoma cells. Br J Cancer (1998) 1.10
Superinfection of Laodelphax striatellus with Wolbachia from Drosophila simulans. Heredity (Edinb) (2003) 1.09
Isolation of chromatin-free RNA polymerase from mammalian cell nuclei. Nature (1968) 1.09
Polyamines inhibit phospholipid-sensitive and calmodulin-sensitive Ca2+-dependent protein kinases. Biochem J (1983) 1.08
Mild pediatric traumatic brain injury: a cohort study. Arch Phys Med Rehabil (1993) 1.06
Transcription termination in animal viruses and cells. Gene (1988) 1.06
Detection of BRCA1 mutations by the protein truncation test. Hum Mol Genet (1995) 1.05
A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function. Oncogene (2001) 1.05
Auto-oxidized cholesterol sulfates are antagonistic ligands of liver X receptors: implications for the development and treatment of atherosclerosis. Steroids (2001) 1.05
In vitro premature termination in SV40 late transcription. EMBO J (1983) 1.02
A kinetic analysis of the nucleotide-induced allosteric transitions of GroEL. J Mol Biol (1999) 1.02
Metabolism of the analgesic drug ULTRAM (tramadol hydrochloride) in humans: API-MS and MS/MS characterization of metabolites. Xenobiotica (2002) 1.01
Antagonistic action of anti-androgens on the formation of a specific dihydrotestosterone-receptor protein complex in rat ventral prostate. Mol Pharmacol (1969) 1.01
Medial neovascularization in abdominal aortic aneurysms: a histopathologic marker of aneurysmal degeneration with pathophysiologic implications. J Vasc Surg (1995) 1.01
Identification and comparison of residues critical for cell-adhesion activities of two neutrophil CD66 antigens, CEACAM6 and CEACAM8. J Leukoc Biol (2001) 1.01
A very rapid effect of androgen on initiation of protein synthesis in prostate. Proc Natl Acad Sci U S A (1975) 1.00
Modulation of obesity by a green tea catechin. Am J Clin Nutr (2000) 1.00
Deletion of a nonconserved region of Bcl-2 confers a novel gain of function: suppression of apoptosis with concomitant cell proliferation. Cancer Res (1996) 0.99
Expression and function of normal and LNCaP androgen receptors in androgen-insensitive human prostatic cancer cells. Altered hormone and antihormone specificity in gene transactivation. Receptor (1991) 0.99
Neurobehavioral sequelae of severe pediatric traumatic brain injury: a cohort study. Arch Phys Med Rehabil (1996) 0.99
Ribonucleoprotein binding of steroid-"receptor" complexes. Nat New Biol (1973) 0.98
Suppression of experimental abdominal aortic aneurysms by systemic treatment with a hydroxamate-based matrix metalloproteinase inhibitor (RS 132908). J Vasc Surg (1999) 0.98
Expression, regulation, and chromosomal localization of the Max gene. Proc Natl Acad Sci U S A (1992) 0.98
Role of the intramolecular phase in high-harmonic generation. Phys Rev Lett (2002) 0.96
The effect Akt2 deletion on tumor development in Pten(+/-) mice. Oncogene (2011) 0.96
Family functioning and injury severity as predictors of child functioning one year following traumatic brain injury. Arch Phys Med Rehabil (1993) 0.96
Association of the uterine 17beta-estradiol-receptor complex with ribonucleoprotein in vitro and in vivo. J Biol Chem (1974) 0.96
Control of late simian virus 40 transcription by the attenuation mechanism and transcriptionally active ternary complexes are associated with the nuclear matrix. J Mol Biol (1984) 0.96
Comparison of indices of traumatic brain injury severity as predictors of neurobehavioral outcome in children. Arch Phys Med Rehabil (1994) 0.95
Ubiquitous receptor: structures, immunocytochemical localization, and modulation of gene activation by receptors for retinoic acids and thyroid hormones. Ann N Y Acad Sci (1995) 0.95
Attenuation and modulation of mRNA secondary structure in a feedback control system regulating SV40 gene expression. Mol Biol Rep (1983) 0.94
Selective activation of liver X receptor alpha by 6alpha-hydroxy bile acids and analogs. Steroids (2000) 0.93
Magnesium and manganese specific forms of soluble liver RNA polymerase. Nature (1969) 0.93
Androgen-sensitive spermine-binding protein of rat ventral prostate. Purification of the protein and characterization of the hormonal effect. Biochem J (1979) 0.93
Molecular action of androgen in the normal and neoplastic prostate. Vitam Horm (1999) 0.91
Immunocytochemical localization of androgen receptors in human skin using monoclonal antibodies against the androgen receptor. J Invest Dermatol (1993) 0.91
A three-dimensional model of the delta-opioid pharmacophore: comparative molecular modeling of peptide and nonpeptide ligands. Biopolymers (2000) 0.91